chanice henry
CRISPR Cas9 Troubleshooting Analysis
October 12 by Pharmaceuticals & Biotechnology EditorThe CRISPR Cas9 tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing. The cutting edge method is being used to revolutionize re...
Trends and Successes in Disposable Tech
September 28 by Chanice Henry“Changes in lifestyles and healthcare systems, and increasing demand for drugs at reduced prices, has led to the development of facilities that can produce more than one product, offering flexibility...
Clinical Trial Supply: Minimising Wastage in Time and Money
September 22 by Pharmaceuticals & Biotechnology EditorThe operation of clinical trials are integral to the progression of the pharmaceutical industry. These trials can be orchestrated on a global scale, producing and distributing the drug in question t...
Your Quarterly Dose of Pharma & Biotech News – Q3
September 15 by Chanice HenryWithin 2015’s third quarter, the pharma and biotech industries saw high levels of landmark discoveries and decisions. Discoveries · Just before the start of Q3 the MHRA revea...
CRISPR CAS9 Emerging Technologies
September 14 by Pharma IQ NewsThe trailblazing CRISPR Cas9 technique has vastly widened the gene editing horizons for the R&D industry. The technique has been gaining popularity since its inception in 2013, with some job adver...
Industry Wide Extractables Study Design Data To Go Live this Quarter
September 08 by Chanice HenryAccording to a recent report, the single use technologies global market is due to grow to around $3bn by 2019. This same report marked extractables and leachables as dominant roadblocks to the singl...
Project Snapshot: CRISPR Cas9
August 28 by Pharmaceuticals & Biotechnology EditorPharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project. [inlinead]...
Serialisation Implementation Timeline
August 25 by Pharmaceuticals & Biotechnology EditorFollowing the release of the EU Falsified Medicines Directive, the pharma market is in the process of becoming fully serialised ahead of 2018’s deadline. Market players currently st...
Exclusive: Interview On GS1’s Traceability Guideline for Brazil
August 19 by Pharmaceuticals & Biotechnology EditorAfter around six months of consultation, global standards organisation GS1 is in the final stages of compiling its Brazilian Medicine Traceability using GS1 EPCIS Part 1 Implementatio...
Top Tips for Future Proof Pharmacovigilance
August 11 by Chanice HenryThe science of pharmacovigilance is rooted in preserving patient care and public safety through “…the detection, assessment, understanding and prevention of adverse effects or any other...
Serialisation: Top Tech Integration Considerations
August 02 by Pharmaceuticals & Biotechnology EditorRoger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone. Life loss, he estimates, equat...
Serialisation Deadlines- Printable WorldMap
July 28 by Pharmaceuticals & Biotechnology EditorAs the pharmaceutical industry prepares for various approaching serialisation deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide compliance effor...